Patent details
EP1471919 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST
Basic Information
- Publication number:
- EP1471919
- PCT Application Number:
- PCT/GB/2003/000491
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037066834
- PCT Publication Number:
- WO/2003/066063
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES COMPRENANT 17ALPHA-FURANYLESTERS DE 17BETA-CARBOTHIOATE ANDROSTANES AVEC UN ANTAGONISTE DES RECEPTEURS MUSCARINIQUES
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND 17ALPHA-FURANYLESTER VON 17BETA-CARBOTHIOAT ANDROSTANDERIVATEN UND EINEN MUSKARINREZEPTORANTAGONIST
- SPC Number:
Dates
- Filing date:
- 04/02/2003
- Grant date:
- 10/08/2005
- EP Publication Date:
- 10/08/2005
- PCT Publication Date:
- 14/08/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/11/2004
- EP B1 Publication Date:
- 10/08/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 04/02/2006
- Expiration date:
- 04/02/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/02/2003
- Name:
- GLAXO GROUP LIMITED
- Address:
- Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom (GB)
Inventor
- Name:
- BIGGADIKE Keith GlaxoSmithKline
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0202635
- Priority Date:
- 05/02/2002
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/58;
| Filing date | Document type | Number of pages |
|---|